Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Ying Ou
Tommi Salmi
Jason Paik
Date of Patent
October 17, 2023
Patent Application Number
18098938
Date Filed
January 19, 2023
Patent Citations
Patent Primary Examiner
Patent abstract
Provided herein is a method of treating a patient having a B-cell proliferative disorder, the method comprising administering to the patient zanubrutinib, or a pharmaceutically acceptable salt thereof, wherein the patient is characterized by being administered with a moderate CYP3A inducer. In one embodiment, zanubrutinib is administered at a dose of about 320 mg twice a day, or at a total daily dose of about 640 mg.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
